news updates and press releases
news updates and press releases
news updates and press releases
news updates and press releases
news updates and press releases
news updates and press releases
news updates and press releases
news updates and press releases
SEO related. Do not remove this box.
Recent publishing
Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
no category
9 May 2023
Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies Funds will advance the company’s lead program into preclinical development 9 May 2023, Naarden, The Netherlands – Phlox Therape...
Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases
no category
11 January 2023
Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Card...
Phlox Therapeutics closes seed investment round
Press Release
16 May 2022
Company’s technology set to revolutionize the treatment of genetic cardiovascular diseases through its development of RNA-based therapeutics May 2020, Naarden, The Netherlands – Phlox Therapeutics, a biotech spin-off of the Amsterd...
Founded
Internal Updates
21 September 2021
March 7th, 2022 – On the basis of more than 15 years of scientific efforts in the lab of Yigal Pinto, he, Eva van Rooij and Margien Boels have now officially founded Phlox Therapeutics B.V. as an Amsterdam UMC spin-off, funded by the FIRS...
Updates
Founded
Internal Updates
21 September 2021
March 7th, 2022 – On the basis of more than 15 years of scientific efforts in the lab of Yigal Pinto, he, Eva van Rooij and Margien Boels have now officially founded Phlox Therapeutics B.V. as an Amsterdam UMC spin-off, funded by the FIRS...
Press releases
Phlox Therapeutics closes seed investment round
Press Release
16 May 2022
Company’s technology set to revolutionize the treatment of genetic cardiovascular diseases through its development of RNA-based therapeutics May 2020, Naarden, The Netherlands – Phlox Therapeutics, a biotech spin-off of the Amsterd...
Related Articles
blog
Blog is now empty.
Recent publishing
Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
no category
9 May 2023
Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies Funds will advance the company’s lead program into preclinical development 9 May 2023, Naarden, The Netherlands – Phlox Therape...
Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases
no category
11 January 2023
Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Card...
Phlox Therapeutics closes seed investment round
Press Release
16 May 2022
Company’s technology set to revolutionize the treatment of genetic cardiovascular diseases through its development of RNA-based therapeutics May 2020, Naarden, The Netherlands – Phlox Therapeutics, a biotech spin-off of the Amsterd...
Founded
Internal Updates
21 September 2021
March 7th, 2022 – On the basis of more than 15 years of scientific efforts in the lab of Yigal Pinto, he, Eva van Rooij and Margien Boels have now officially founded Phlox Therapeutics B.V. as an Amsterdam UMC spin-off, funded by the FIRS...
Updates
Founded
Internal Updates
21 September 2021
March 7th, 2022 – On the basis of more than 15 years of scientific efforts in the lab of Yigal Pinto, he, Eva van Rooij and Margien Boels have now officially founded Phlox Therapeutics B.V. as an Amsterdam UMC spin-off, funded by the FIRS...
Press releases
Phlox Therapeutics closes seed investment round
Press Release
16 May 2022
Company’s technology set to revolutionize the treatment of genetic cardiovascular diseases through its development of RNA-based therapeutics May 2020, Naarden, The Netherlands – Phlox Therapeutics, a biotech spin-off of the Amsterd...
Related Articles
blog
Blog is now empty.